| RS386134241 |
IKBKG
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia and immunodeficiency 1, Ectodermal dysplasia and immunodeficiency 1 |
| RS386134243 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Charcot-Marie-Tooth disease type 2 |
| RS386134245 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134246 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134247 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134249 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134250 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134251 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134253 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134254 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134255 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134256 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134258 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134259 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134260 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134261 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386134262 |
NR0B1
|
Health Risk |
Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS386134263 |
NR0B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital adrenal hypoplasia, X-linked |
| RS386134267 |
HNF1A
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 3, Maturity-onset diabetes of the young |
| RS386134269 |
TTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyloidosis, hereditary systemic 1 |
| RS386134270 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS386134271 |
MECP2
|
Health Risk |
Pathogenic |
Rett syndrome, Rett syndrome |
| RS386352291 |
CPAP
|
Health Risk |
Pathogenic |
— |
| RS386352318 |
KCNJ5
|
Health Risk |
Likely pathogenic |
— |
| RS386352319 |
KCNJ5
|
Health Risk |
Likely pathogenic |
Aldosterone-producing adrenal adenoma, somatic |
| RS386352352 |
PRKACA
|
Health Risk |
Pathogenic/Likely pathogenic |
Pigmented nodular adrenocortical disease, primary |
| RS386628081 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS386629678 |
LDLRAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS386653129 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS386654966 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS386692223 |
MEGF10
|
Health Risk |
Conflicting classifications of pathogenicity |
MEGF10-related myopathy, MEGF10-related myopathy |
| RS386699797 |
TAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
MHC class I deficiency, MHC class I deficiency |
| RS386707192 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Autosomal recessive ataxia |
| RS386716957 |
PPP1R3A
|
Health Risk |
association |
GLYCEMIA VARIATION, GLYCEMIA VARIATION |
| RS386742210 |
ANKRD26
|
Health Risk |
Conflicting classifications of pathogenicity |
Thrombocytopenia 2, Thrombocytopenia 2 |
| RS386743165 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 2 |
| RS386789728 |
CRYM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS386802145 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS386833394 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS386833397 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS386833402 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS386833403 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS386833406 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome 1, Hereditary cancer-predisposing syndrome |
| RS386833412 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS386833416 |
TRIM37
|
Health Risk |
Pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS386833417 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833418 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833419 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833420 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833421 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833422 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833423 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833424 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833425 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833426 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833427 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833429 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833430 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Inborn genetic diseases |
| RS386833431 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833432 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833433 |
AGA
|
Health Risk |
Pathogenic/Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833434 |
AGA
|
Health Risk |
Conflicting classifications of pathogenicity |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833435 |
AGA
|
Health Risk |
Likely pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833436 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Inborn genetic diseases |
| RS386833437 |
AGA
|
Health Risk |
Pathogenic |
Aspartylglucosaminuria, Aspartylglucosaminuria |
| RS386833439 |
CSTB
|
Health Risk |
Likely pathogenic |
Unverricht-Lundborg syndrome, Unverricht-Lundborg syndrome |
| RS386833440 |
CSTB
|
Health Risk |
Likely pathogenic |
Unverricht-Lundborg syndrome, Glioma susceptibility 1 |
| RS386833441 |
CSTB
|
Health Risk |
Likely pathogenic |
Unverricht-Lundborg syndrome, Unverricht-Lundborg syndrome |
| RS386833443 |
CSTB
|
Health Risk |
Likely pathogenic |
Unverricht-Lundborg syndrome, Unverricht-Lundborg syndrome |
| RS386833444 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833445 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833447 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833448 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833449 |
SLC26A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833450 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833451 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833452 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833453 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833454 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833455 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833456 |
SLC26A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833457 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833458 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833459 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833460 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833461 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833462 |
SLC26A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital secretory diarrhea, chloride type |
| RS386833463 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833465 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833466 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833467 |
SLC26A3
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833468 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833469 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833471 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833472 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833473 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833474 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833475 |
SLC26A3
|
Health Risk |
Likely pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833476 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |
| RS386833477 |
SLC26A3
|
Health Risk |
Pathogenic |
Congenital secretory diarrhea, chloride type |